Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Tobacco Induced Diseases
Published in: Tobacco Induced Diseases 1/2015

Open Access 01-12-2015 | Research

Prevalence of smoking in adults with chronic pain

Authors: Vwaire J. Orhurhu, Thomas P. Pittelkow, W. Michael Hooten

Published in: Tobacco Induced Diseases | Issue 1/2015

Login to get access

Abstract

Introduction

Cigarette smoking is common among adults with chronic pain. The primary objective of this study was to determine the period prevalence of smoking in patients with chronic pain. A secondary objective was to determine the prevalence of smoking among patients with commonly occurring pain diagnoses including fibromyalgia, low back pain, and headache.

Methods

This population study included 5350 patients (1256 smokers, 4094 nonsmokers) admitted to the Mayo Comprehensive Pain Rehabilitation Center from January 1998 through December 2012. Smoking status was determined using a self-report questionnaire.

Results

During the 15 year study period, the overall prevalence of smoking was 23.5 % (95 % CI 22.4 – 24.6). The prevalence of smoking in 2000, 2005, and 2010 was 24.2, 25.7, and 28.3 % respectively. The overall prevalence of smoking in patients with fibromyalgia, low back pain, and headache was 25.2 % (95 % CI 22.8 – 28.3), 22.8 % (95 % CI 21.3 – 25.9), and 21.2 % (95 % CI 17.9 – 24.7), respectively. In a multiple variable logistic model adjusted for age and sex, opioid use was significantly associated with status as a current smoker.

Conclusion

The prevalence of smoking in patients with chronic pain has not declined when compared to the general population. The higher prevalence of smoking was consistently observed in commonly occurring pain diagnoses including fibromyalgia, back pain, and headache. Further research is needed to identify the potential factors that contribute to the high prevalence of smoking in this patient population.
Literature
1.
Aamodt AH, Stovner LJ, Hagen K, Brathen G, Zwart J. Headache prevalence related to smoking and alcohol use. The Head-HUNT Study. Eur J Neurol. 2006;13:1233–8.PubMedCrossRef
2.
Agaku IT, King BA, Dube SR. Current cigarette smoking among adults - United States, 2005-2012. MMWR Morb Mortal Wkly Rep. 2014;63:29–34.PubMed
3.
Alkherayf F, Agbi C. Cigarette smoking and chronic low back pain in the adult population. Clin Invest Med. 2009;32:E360–7.PubMed
4.
Andersson H, Ejlertsson G, Leden I. Widespread musculoskeletal chronic pain associated with smoking. An epidemiological study in a general rural population. Scand J Rehabil Med. 1998;30:185–91.PubMedCrossRef
5.
Bjorck-van Dijken C, Fjellman-Wiklund A, Hildingsson C. Low back pain, lifestyle factors and physical activity: a population based-study. J Rehabil Med. 2008;40:864–9.PubMedCrossRef
6.
Centers for Disease Control and Prevention (CDC). Cigarette smoking among adults--United States, 2000. MMWR Morb Mortal Wkly Rep. 2002;51:642–5.
7.
Centers for Disease Control and Prevention (CDC). Vital signs: current cigarette smoking among adults aged >/=18 years--United States, 2005-2010. MMWR Morb Mortal Wkly Rep. 2011;60:1207–12.
8.
Fernandez-de-Las-Penas C, Hernandez-Barrera V, Carrasco-Garrido P, Alonso-Blanco C, Palacios-Cena D, Jimenez-Sanchez S, et al. Population-based study of migraine in Spanish adults: relation to socio-demographic factors, lifestyle and co-morbidity with other conditions. J Headache Pain. 2010;11:97–104.PubMedCentralPubMedCrossRef
9.
Fishbain DA, Lewis JE, Bruns D, Meyer LJ, Gao J, Disorbio JM. The prevalence of smokers within chronic pain patients and highest pain levels versus comparison groups. Pain Med. 2012;14:403–16.PubMedCrossRef
10.
Goesling J, Brummett CM, Hassett AL. Cigarette smoking and pain: depressive symptoms mediate smoking-related pain symptoms. Pain. 2012;153:1749–54.PubMedCrossRef
11.
Hestbaek L, Leboeuf-Yde C, Kyvik KO. Are lifestyle-factors in adolescence predictors for adult low back pain? A cross-sectional and prospective study of young twins. BMC Musculoskelet Disord. 2006;7:27.PubMedCentralPubMedCrossRef
12.
Hooten WM, Knight-Brown M, Townsend CO, Laures HJ. Clinical outcomes of multidisciplinary pain rehabilitation among african american compared with caucasian patients with chronic pain. Pain Med. 2012;13:1499–508.PubMedCrossRef
13.
Hooten WM, Shi Y, Gazelka HM, Warner DO. The effects of depression and smoking on pain severity and opioid use in patients with chronic pain. Pain. 2010;152:223–9.PubMedCentralPubMedCrossRef
14.
Hooten WM, Townsend CO, Bruce BK, Schmidt JE, Kerkvliet JL, Patten CA, et al. Effects of smoking status on immediate treatment outcomes of multidisciplinary pain rehabilitation. Pain Med. 2009;10:347–55.PubMedCrossRef
15.
Hooten WM, Townsend CO, Bruce BK, Shi Y, Warner DO. Sex differences in characteristics of smokers with chronic pain undergoing multidisciplinary pain rehabilitation. Pain Med. 2009;10:1416–25.PubMedCrossRef
16.
Hooten WM, Townsend CO, Bruce BK, Warner DO. The effects of smoking status on opioid tapering among patients with chronic pain. Anesth Analg. 2009;108:308–15.PubMedCrossRef
17.
Hooten WM, Townsend CO, Hays JT, Ebnet KL, Gauvin TR, Gehin JM, et al. A cognitive behavioral smoking abstinence intervention for adults with chronic pain: a randomized controlled pilot trial. Addict Behav. 2013;39:593–9.PubMedCentralPubMedCrossRef
18.
Hooten WM, Vickers KS, Shi Y, Ebnet KL, Townsend CO, Patten CA, et al. Smoking cessation and chronic pain: patient and pain medicine physician attitudes. Pain Pract. 2011;11:552–63.PubMedCentralPubMedCrossRef
19.
John U, Hanke M, Meyer C, Volzke H, Baumeister SE, Alte D. Tobacco smoking in relation to pain in a national general population survey. Prev Med. 2006;43:477–81.PubMedCrossRef
20.
Kaila-Kangas L, Leino-Arjas P, Riihimaki H, Luukkonen R, Kirjonen J. Smoking and overweight as predictors of hospitalization for back disorders. Spine. 2003;28:1860–8.PubMedCrossRef
21.
Leboeuf-Yde C. Smoking and low back pain. A systematic literature review of 41 journal articles reporting 47 epidemiologic studies. Spine (Phila Pa 1976). 1999;24:1463–70.CrossRef
22.
Leclerc A, Gourmelen J, Chastang JF, Plouvier S, Niedhammer I, Lanoe JL. Level of education and back pain in France: the role of demographic, lifestyle and physical work factors. Int Arch Occup Environ Health. 2009;82:643–52.PubMedCentralPubMedCrossRef
23.
Lee SS, Kim SH, Nah SS, Lee JH, Lee YA, Hong SJ, et al. Smoking habits influence pain and functional and psychiatric features in fibromyalgia. Joint Bone Spine. 2011;78:259–65.PubMedCrossRef
24.
Mattila VM, Sahi T, Jormanainen V, Pihlajamaki H. Low back pain and its risk indicators: a survey of 7,040 Finnish male conscripts. Eur Spine J. 2008;17:64–9.PubMedCentralPubMedCrossRef
25.
Oh TH, Hoskin TL, Luedtke CA, Weingarten TN, Vincent A, Kim CH, et al. Predictors of clinical outcome in fibromyalgia after a brief interdisciplinary fibromyalgia treatment program: single center experience. PM R. 2012;4:257–63.PubMedCrossRef
26.
Palmer KT, Syddall H, Cooper C, Coggon D. Smoking and musculoskeletal disorders: findings from a British national survey. Ann Rheum Dis. 2003;62:33–6.PubMedCentralPubMedCrossRef
27.
Pamuk ON, Donmez S, Cakir N. The frequency of smoking in fibromyalgia patients and its association with symptoms. Rheumatol Int. 2009;29:1311–4.PubMedCrossRef
28.
Power C, Frank J, Hertzman C, Schierhout G, Li L. Predictors of low back pain onset in a prospective British study. Am J Public Health. 2001;91:1671–8.PubMedCentralPubMedCrossRef
29.
Sarker MA, Rahman M, Harun-Or-Rashid M, Hossain S, Kasuya H, Sakamoto J, et al. Association of smoked and smokeless tobacco use with migraine: a hospital-based case-control study in Dhaka, Bangladesh. Tob Induc Dis. 2013;11:15.PubMedCentralPubMedCrossRef
30.
Schmidt BL, Tambeli CH, Gear RW, Levine JD. Nicotine withdrawal hyperalgesia and opioid-mediated analgesia depend on nicotine receptors in nucleus accumbens. Neuroscience. 2001;106:129–36.PubMedCrossRef
31.
Scott SC, Goldberg MS, Mayo NE, Stock SR, Poitras B. The association between cigarette smoking and back pain in adults. Spine (Phila Pa 1976). 1999;24:1090–8.CrossRef
32.
Shiri R, Karppinen J, Leino-Arjas P, Solovieva S, Viikari-Juntura E. The association between smoking and low back pain: a meta-analysis. Am J Med. 2010;123:87. e7-35.PubMedCrossRef
33.
Simons CT, Cuellar JM, Moore JA, Pinkerton KE, Uyeminami D, Carstens MI, et al. Nicotinic receptor involvement in antinociception induced by exposure to cigarette smoke. Neurosci Lett. 2005;389:71–6.PubMedCrossRef
34.
Suh HW, Song DK, Lee KJ, Choi SR, Kim YH. Intrathecally injected nicotine enhances the antinociception induced by morphine but not beta-endorphin, D-Pen2,5-enkephalin and U50,488H administered intrathecally in the mouse. Neuropeptides. 1996;30:373–8.PubMedCrossRef
35.
Takeshima T, Ishizaki K, Fukuhara Y, Ijiri T, Kusumi M, Wakutani Y, et al. Population-based door-to-door survey of migraine in Japan: the Daisen study. Headache. 2004;44:8–19.PubMedCrossRef
36.
Vogt MT, Hanscom B, Lauerman WC, Kang JD. Influence of smoking on the health status of spinal patients: the National Spine Network database. Spine (Phila Pa 1976). 2002;27:313–9.CrossRef
37.
Watkins EA, Wollan PC, Melton 3rd LJ, Yawn BP. A population in pain: report from the Olmsted County health study. Pain Med. 2008;9:166–74.PubMedCrossRef
38.
Weingarten TN, Moeschler SM, Ptaszynski AE, Hooten WM, Beebe TJ, Warner DO. An assessment of the association between smoking status, pain intensity, and functional interference in patients with chronic pain. Pain Physician. 2008;11:643–53.PubMed
39.
Weingarten TN, Podduturu VR, Hooten WM, Thompson JM, Luedtke CA, Oh TH. Impact of tobacco use in patients presenting to a multidisciplinary outpatient treatment program for fibromyalgia. Clin J Pain. 2009;25:39–43.PubMedCrossRef
40.
Yunus MB, Arslan S, Aldag JC. Relationship between fibromyalgia features and smoking. Scand J Rheumatol. 2002;31:301–5.PubMedCrossRef
41.
Zvolensky MJ, McMillan K, Gonzalez A, Asmundson GJ. Chronic pain and cigarette smoking and nicotine dependence among a representative sample of adults. Nicotine Tob Res. 2009;11:1407–14.PubMedCentralPubMedCrossRef
Metadata
Title
Prevalence of smoking in adults with chronic pain
Authors
Vwaire J. Orhurhu
Thomas P. Pittelkow
W. Michael Hooten
Publication date
01-12-2015
Publisher
BioMed Central
Published in
Tobacco Induced Diseases / Issue 1/2015
Electronic ISSN: 1617-9625
DOI
https://doi.org/10.1186/s12971-015-0042-y

Other articles of this Issue 1/2015

Tobacco Induced Diseases 1/2015 Go to the issue

Research

Tobacco and end stage renal disease: a multicenter, cross-sectional study in Argentinian Northern Patagonia

Research

Potential harmful health effects of inhaling nicotine-free shisha-pen vapor: a chemical risk assessment of the main components propylene glycol and glycerol

Research

Twitter users’ reaction to a chain pharmacy’s decision to end tobacco sales

Research

Fidelity monitoring across the seven studies in the Consortium of Hospitals Advancing Research on Tobacco (CHART)

Research

Use of snus, its association with smoking and alcohol consumption, and related attitudes among adolescents: the Finnish National School Health Promotion Study

Research

Positive and instructive anti-smoking messages speak to older smokers: a focus group study
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine
Image Credits